Targeted therapy in advanced desmoid tumors: Current perspectives Cover

.blurhash-client-img { display: none !important; }

Targeted therapy in advanced desmoid tumors: Current perspectives

Forum of Clinical Oncology

Volume 11 (2020): Issue 3 (December 2020)

By: Amrallah A. Mohammed, Hani EL-Tanni and Hani M. EL-Khatib

Open Access

|Apr 2021

Authors

Amrallah A. Mohammed

amrallaabdelmoneem@yahoo.com

Department of Medical Oncology, Faculty of Medicine, Zagazig University, Zagazig, Egypt

Hani EL-Tanni

King Salman Armed Forces Hospital, Tabuk City, Saudi Arabia

Hani M. EL-Khatib

Oncology Center, King Abdullah Medical City-Holy Capital, Makkah, Saudi Arabia

DOI: https://doi.org/10.2478/fco-2019-0023 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X

Journal RSS Feed

Language: English

Page range: 9 - 16

Submitted on: Nov 21, 2020

Accepted on: Dec 11, 2020

Published on: Apr 22, 2021

Published by: Helenic Society of Medical Oncology

In partnership with: Paradigm Publishing Services

Publication frequency: 2 issues per year

Keywords:

Desmoid tumors,

aggressive fibromatosis,

targeted therapy,

molecular pathogenesis

Related subjects:

Clinical medicine,

Internal medicine,

Haematology, oncology

© 2021 Amrallah A. Mohammed, Hani EL-Tanni, Hani M. EL-Khatib, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous article Volume 11 (2020): Issue 3 (December 2020)Next article